On ECHEMI
Home > Drugs > Acute fatty liver of pregnancy
Acute fatty liver of pregnancy
Acute fatty liver of pregnancy, also known as acute pseudo-yellow hepatic atrophy in obstetrics, is a rare fatal disease unique to late pregnancy. The disease has an acute onset and changes rapidly, and its clinical manifestations are similar to fulminant hepatitis. Previous literature reports that the maternal and infant mortality rates are 75% and 85%, respectively. However, if early diagnosis, early treatment, and timely termination of pregnancy can be achieved, the maternal mortality rate can be reduced, and the infant mortality rate can be reduced to 58.3%.
  • Site of disease:

    Liver Female Reproductive
  • Infectious :

    Not contagious
  • Frequent population:

    Pregnant women
  • Related symptoms:

    Nausea stomach ache fatigue polyuria gum bleeding
  • Concurrent disease:

Related Drugs
Lecithin tablets
Indication: Used as an auxiliary treatment for diseases such as fatty liver and atherosclerosis.
Manufacturer:

Harbin Hanjun Modern Pharmaceutical Co., Ltd.

Lecithin tablets
Indication: Used as an auxiliary treatment for diseases such as fatty liver and atherosclerosis.
Manufacturer:

Jiuquan Dadeli Pharmaceutical Co., Ltd.

Zhen Xiong Dan Wan
Manufacturer:

Yunnan Dali Ruihe Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.